Background: It is uncommon for patients who have received a permanent implant to remove the spinal cord stimulator (SCS) after discontinuation of medication in complex regional pain syndrome (CRPS) due to their completely painless state. This study evaluated CRPS patients who successfully removed th...
Background: It is uncommon for patients who have received a permanent implant to remove the spinal cord stimulator (SCS) after discontinuation of medication in complex regional pain syndrome (CRPS) due to their completely painless state. This study evaluated CRPS patients who successfully removed their SCSs. Methods: This 10-year retrospective study was performed on patients who had received the permanent implantation of an SCS and had removed it 6 months after discontinuation of stimulation, while halting all medications for neuropathic pain. Age, sex, duration of implantation, site and type of CRPS, and their return to work were compared between the removal and non-removal groups. Results: Five (12.5%, M/F = 4/1) of 40 patients (M/F = 33/7) successfully removed the permanent implant. The mean age was younger in the removal group ($27.2{\pm}6.4$ vs. $43.5{\pm}10.7$ years, P < 0.01). The mean duration of implantation in the removal group was $34.4{\pm}18.2$ months. Two of 15 patients (13.3%) and 3 of 25 patients (12%) who had upper and lower extremity pain, respectively, had removed the implant. The implants could be removed in 5 of 27 patients (18.5%) with CRPS type 1 (P < 0.01). All 5 patients (100%) who removed their SCS returned to work, while only 5 of 35 (14.3%) in the non-removal group did (P < 0.01). Conclusions: Even though this study had limited data, younger patients with CRPS type 1 could remove their SCSs within a 5-year period and return to work with complete pain relief.
Background: It is uncommon for patients who have received a permanent implant to remove the spinal cord stimulator (SCS) after discontinuation of medication in complex regional pain syndrome (CRPS) due to their completely painless state. This study evaluated CRPS patients who successfully removed their SCSs. Methods: This 10-year retrospective study was performed on patients who had received the permanent implantation of an SCS and had removed it 6 months after discontinuation of stimulation, while halting all medications for neuropathic pain. Age, sex, duration of implantation, site and type of CRPS, and their return to work were compared between the removal and non-removal groups. Results: Five (12.5%, M/F = 4/1) of 40 patients (M/F = 33/7) successfully removed the permanent implant. The mean age was younger in the removal group ($27.2{\pm}6.4$ vs. $43.5{\pm}10.7$ years, P < 0.01). The mean duration of implantation in the removal group was $34.4{\pm}18.2$ months. Two of 15 patients (13.3%) and 3 of 25 patients (12%) who had upper and lower extremity pain, respectively, had removed the implant. The implants could be removed in 5 of 27 patients (18.5%) with CRPS type 1 (P < 0.01). All 5 patients (100%) who removed their SCS returned to work, while only 5 of 35 (14.3%) in the non-removal group did (P < 0.01). Conclusions: Even though this study had limited data, younger patients with CRPS type 1 could remove their SCSs within a 5-year period and return to work with complete pain relief.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
제안 방법
This study evaluated patients who successfully removed the SCS in CRPS cases retrospectively according to age, sex, type of CRPS, involved extremity, duration between an initiating noxious event to implantation, and duration of implantation of the SCS.
데이터처리
Demographic data included age and sex distribution of the total number and the number of each group in the removal and non-removal group who had received a permanent SCS. The mean age in both groups was compared, using an independent t-test. The gender ratio in both groups was compared using the chi-squared test.
The site and type of CRPS, and their returning to work (yes or no), were calculated as a percentile from each group, and compared both groups analyzed with the chi-squared test.
이론/모형
The mean age in both groups was compared, using an independent t-test. The gender ratio in both groups was compared using the chi-squared test.
성능/효과
Even though this study had a limited number of data, relatively young patients with CRPS type 1 had a better prognosis for complete pain relief after SCS implantation, and could remove the SCS within a 5-year period (17-59 months) and return to their work.
In conclusion, only young patients with CRPS type 1 could remove a permanent SCS within 5 years and return to work with complete relief of pain, regardless of sex, site of CRPS, mean duration of an initiating event to implantation, mean duration of implantation, and type of insurance in this study.
참고문헌 (12)
1 Poree L Krames E Pope J Deer TR Levy R Schultz L Spinal cord stimulation as treatment for complex regional pain syndrome should be considered earlier than last resort therapy Neuromodulation 2013 16 125 141 23441988
4 Kemler MA Barendse GA van Kleef M de Vet HC Rijks CP Furnée CA S pinal cord stimulation i n patients w ith chronic reflex sympathetic dystrophy N Engl J Med 2000 343 618 624 10965008
5 Kemler MA De Vet HC Barendse GA Van Den Wildenberg FA Van Kleef M The effect o f spinal c ord stimulation i n patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial Ann Neurol 2004 55 13 18 14705107
6 Kemler MA de Vet HC Barendse GA van den Wildenberg FA van Kleef M Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial J Neurosurg 2008 108 292 298 18240925
8 Sharan AD Riley J Falowski S Pope JE Connolly AT Karst E Association of opioid usage with spinal cord stimulation outcomes Pain Med 2018 19 699 707 29244102
9 Celestin J Edwards RR Jamison RN Pretreatment psychosocial variables as predictors of outcomes following lumbar surgery and spinal cord stimulation: a systematic review and literature synthesis Pain Med 2009 10 639 653 19638142
12 Hoehn-Saric R McLeod DR The peripheral sympathetic nervous system. Its role in normal and pathologic anxiety Psychiatr Clin North Am 1988 11 375 386 3047706
※ AI-Helper는 부적절한 답변을 할 수 있습니다.